FDA Drug Application (202764) for GABAPENTIN by INVAGEN PHARMS

Back to FDA Applications sponsored by INVAGEN PHARMS

Application Number202764
Product Number001
FormTABLET;ORAL
Dosage600MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameGABAPENTIN
Active IngredientGABAPENTIN

Active IngredientCount
List of drugs with Active Ingredient GABAPENTIN3


Back to FDA Applications sponsored by INVAGEN PHARMS